Clinical Trial Update: Sitagliptin for Reducing Inflammation and Immune Activation [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating sitagliptin to reduce inflammation and immune activation in HIV-1 infection, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: HIV-1 Infection | Phase 2 | Status: COMPLETED | Results posted: 2018-01-05